Publication | Open Access
Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
74
Citations
17
References
2017
Year
EudraCT number: 2014-000349-59.
| Year | Citations | |
|---|---|---|
Page 1
Page 1